Close Menu
Home » Agilent, MRM Proteomics Extend Co-marketing Agreement

Agilent, MRM Proteomics Extend Co-marketing Agreement

Jul 24, 2014
|
staff reporter

NEW YORK (GenomeWeb) – Agilent Technologies today announced the extension of a co-marketing agreement with MRM Proteomics.

The extension expands a deal between the companies reached in September 2012, and will allow the partners to improve their combined proteomics solutions comprising reagents kits, hardware, and software, Agilent said.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Nobel Representation

In a cartoon, Vox explores the lack of women among this year's winners of the Nobel Prize.

Bill to Address Foreign Influence

Science reports a new US defense bill would establish two groups aimed at combating foreign influence on research. 

Promising, But More Needed

Nature Biotechnology discusses promising early results from two clinical trials of CRISPR-based therapy for β-thalassemia and sickle cell disease.

Cell Studies Tackle Tissue Clones, Ocean Microbes, Polygenic Trait Prediction

In Cell this week: analysis of tissue clones, metagenomic studies of ocean water samples, and more.

What's Popular?

In Proteomics & Protein Research

  1. Neural Net-Based Software Offers Boost to Proteomics Throughput

    Premium

  2. Researchers Use Machine Learning to Map Functional Relevance of Human Phosphoproteome

  3. Akoya Biosciences Closes $50M Funding Round

  4. Canopy Biosciences Acquires Biopharma Services Firm Core Diagnostics

  5. Alzheimer's Drug Discovery Foundation Awards $5.5M in Grants for Diagnostic Development

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.